DexCom (NASDAQ: DXCM) reported Q3 EPS of $0.61, $0.04 better than the analyst estimate of $0.57. Revenue for the quarter came in at $1.21 billion versus the consensus estimate of $1.18 billion.

GUIDANCE:

DexCom sees FY2025 revenue of $4.63-4.65 billion, versus the consensus of $4.62 billion.

For earnings history and earnings-related data on DexCom (DXCM) click here.